Pathway Genomics: Unlocking the DNA to Effectively Battle Depression

At least 350 million people across the globe suffer from some degree of depression, making this the most prominent cause of disability according to a recent report from the World Health Organization. Though an estimated 90 percent of these cases can be mitigated, not all treatments are appropriate for all who face this condition. Pathway Genomics has discovered the key to finding solutions lies not only in the available treatments, but in individual DNA.

What Types of Medications are Used to Treat Depression?

While prescriptions geared toward depression were once in limited supply, they’ve branched out considerably in recent years. Pharmaceutical companies have developed a wide range of medication types for the treatment of this illness with even more specific options falling under each category. Some of the solutions currently available include:

  • Mood Stabilizers: Typically used for bipolar disorders, mood stabilizers help level out the often severe emotional shifts often associated with this condition.
  • Antipsychotics: Some depressive situations stem from impaired mental function. Antipsychotics affect the brain’s neurotransmitters to help combat this issue.
  • SSRIs: With certain cases of depression being caused by serotonin deficiency, SSRIs are used to increase the body’s natural levels of this hormone.
  • SNRIs: Like SSRIs, SNRIs ramp up serotonin levels while also targeting norepinephrine-producing cells.

These are only a few of the medications now being used to thwart depression. Many others combat the illness in different ways. Though each is effective when paired with the type of depression it’s meant to treat, they can cause negative side-effects for some people.

Which One is Right for Me?

If you’re suffering from depression, finding the right medication, or combination of them, depends on a number of factors. No two human bodies process medications in the same way, and this is the reason a certain type of antidepressant might work for one person but not for another. Just how the body metabolizes these drugs also determines which of the side-effects a specific person will experience.

Pathway Genomics aids in the search for the right cure for each individual. The company does so by unlocking a person’s unique DNA to learn how his or her body will respond to a certain type of medication from both positive and negative angles. Once this secret has been unearthed, the path to an effective treatment becomes shorter and less precarious.

This entry was posted in Health & Fitness. Bookmark the <a href="" title="Permalink to Pathway Genomics: Unlocking the DNA to Effectively Battle Depression" rel="bookmark">permalink</a>.